医学
结肠镜检查
腺瘤
随机对照试验
结直肠癌
内科学
退出时间
临床终点
放射科
胃肠病学
核医学
癌症
作者
David Karsenti,Guillaume Perrod,Bastien Perrot,Lucille Quénéhervé,Édouard Chabrun,Stéphane Koch,Geoffroy Vanbiervliet,Gabriel Rahmi,Guillaume Velut,Maira Moreno-Garcia,Maryan Cavicchi,Xavier Dray
出处
期刊:Endoscopy
[Thieme Medical Publishers (Germany)]
日期:2024-05-13
卷期号:56 (10): 759-767
被引量:5
摘要
Abstract Background Missed lesions are common during standard colonoscopy and are correlated with post-colonoscopy colorectal cancer. Contrast-enhanced technologies have recently been developed to improve polyp detection. We aimed to evaluate the impact of linked color imaging (LCI) on the proximal adenoma miss rate in routine colonoscopy. Methods This national, multicenter, tandem, randomized trial compared the outcomes of colonoscopy with white-light imaging (WLI) versus LCI for polyp detection in the right colon. Two consecutive examinations of the right colon (upstream of the hepatic flexure) were made with WLI and LCI by the same operator. First-pass examination by WLI or LCI was randomized 1:1 after cecal intubation. According to statistical calculations, 10 endoscopy units had to include approximately 700 patients. The primary outcome was proximal adenoma miss rate. Secondary outcomes were the proximal miss rates for sessile serrated lesions (SSL), advanced adenomas, and polyps. Results 764 patients were included from 1 January 2020 to 22 December 2022, and 686 patients were randomized (345 WLI first vs. 341 LCI first). Both groups were comparable in terms of demographics and indications. The proximal adenoma miss rate was not significantly higher in the WLI-first group (36.7%) vs. the LCI-first group (31.8%) (estimated mean absolute difference: 4.9% [95%CI –5.2% to 15.0%], P = 0.34). There was also no significant difference in miss rates for SSLs, advanced adenomas, and polyps in the proximal colon. Conclusions In contrast to previous data, this study does not support the benefit of LCI to the proximal adenoma miss rate in routine colonoscopy.
科研通智能强力驱动
Strongly Powered by AbleSci AI